The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Open accessAbstract
Otto Warburg's theory on the origins of cancer postulates that tumor cells have defects in mitochondrial oxidative phosphorylation and therefore rely on high levels of aerobic glycolysis as the major source of ATP to fuel cellular proliferation (the Warburg effect). This is in contrast to normal cells, which primarily utilize oxidative phosphorylation for growth and survival. Here we report that the major function of glucose metabolism for Kras-induced anchorage-independent growth, a hallmark of transformed cells, is to support the pentose phosphate pathway. The major function of glycolytic ATP is to support growth under hypoxic conditions. Glutamine conversion into the tricarboxylic acid cycle intermediate alpha-ketoglutarate through glutaminase and alanine aminotransferase is essential for Kras-induced anchorage-independent growth. Mitochondrial metabolism allows for the generation of reactive oxygen species (ROS) which are required for Kras-induced anchorage-independent growth through regulation of the ERK MAPK signaling pathway. We show that the major source of ROS generation required for anchorage-independent growth is the Q o site of mitochondrial complex III. Furthermore, disruption of mitochondrial function by loss of the mitochondrial transcription factor A (TFAM) gene reduced tumorigenesis in an oncogenic Kras-driven mouse model of lung cancer. These results demonstrate that mitochondrial metabolism and mitochondrial ROS generation are essential for Kras-induced cell proliferation and tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Providing cells with αKG, oxaloacetate, or pyruvate is sufficient to rescue cancer cell proliferation in conditions of glutamine starvation, confirming that glutamine supports proliferation by replenishing depleted TCA cycle intermediates, a process termed anaplerosis (Altman et al., 2016; Weinberg et al., 2010; Yuneva et al., 2007).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Weinberg et al., 2010
In the citing paper
“However, KRAS has also been shown to promote cancer cell growth by stimulating alanine aminotransferase activity, leading to high levels of α-ketoglutarate for the TCA cycle and mitochondrial ROS generation, which was required for mutant KRAS-driven tumorigenesis in a mouse model of lung cancer64.”
From The metabolic landscape of RAS-driven cancers from biology to therapy (2021) · cites this paper as [64]
In the citing paper
“A low level of reactive oxygen species (ROS) activates tumorigenic growth signaling; however, when the level exceeds the cellular redox capacity, ROS can damage macromolecules such as proteins, lipids and nucleotides55.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [55]
In the citing paper
“Correspondingly, in K-Ras mutant cells, the oxygen consumption rate and ATP generation are enhanced by glutamine, contributing to tumorigenesis55.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [55]
In the citing paper
“Notably, alanine levels were significantly decreased in Mpc knockdown cells, highlighting a role for mitochondrial pyruvate and mitochondrial alanine aminotransferase (ALT2) in mediating glutamine anaplerosis which was previously described in cancer cells (Weinberg et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Weinberg et al., 2010
In the citing paper
“Another study reported that mitochondrial ROS are necessary for the KRAS (Kirsten rat sarcoma virus)—induced anchored-independent growth of lung cancer.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Weinberg et al. 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,001
Mitochondria as therapeutic targets for cancer stem cells
Song, I. S. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.418 · Cited by 64
Metabolic changes in cancer cells upon suppression of MYC
Ansó, E., Mullen, A. R., Felsher, D. W., Matés, J. M., DeBerardinis, R. J., & Chandel, N. S. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-7 · Cited by 64
Self-citationRecent advances in cancer metabolism: a technological perspective
Kang, Y. P., Ward, N. P., & DeNicola, G. M. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0027-z · Cited by 65
Zhong, C., Long, Z., Yang, T., Wang, S., Zhong, W., Hu, F., Teoh, J. Y., Lü, J., & Mao, X. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.77133 · Cited by 62
The role of fructose in metabolism and cancer
Charrez, B., Qiao, L., & Hebbard, L. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0009 · Cited by 63
CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4
Wang, L., Zhou, H., Wang, Y., Cui, G., & Di, L.-J. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.587 · Cited by 62
Sánchez‐Aragó, M., Formentini, L., & Cuezva, J. M. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4883 · Cited by 63
Vitiello, G. A., Medina, B. D., Zeng, S., Bowler, T. G., Zhang, J. Q., Loo, J. K., Param, N. J., Liu, M., Moral, A. J., Zhao, J. N., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2697 · Cited by 62
Yonashiro, R., Eguchi, K., Wake, M., Takeda, N., & Nakayama, K. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1751 · Cited by 60
Valenti, D., Lidia de, B. A. R. I., Manente, G. A., Rossi, L., Mutti, L., Moro, L., & Vacca, R. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.07.014 · Cited by 61
Mirzaei, S., Gholami, M. H., Mahabady, M. K., Nabavi, N., Zabolian, A., Banihashemi, S. M., Haddadi, A., Entezari, M., Hushmandi, K., Makvandi, P., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111077 · Cited by 61
RetractedEnergy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors
Amoêdo, N. D., Rodrigues, M. F., Pezzuto, P., Galina, A., da Costa, R. M., Almeida, F. C. L., El‐Bacha, T., & Rumjanek, F. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022264 · Cited by 68
MicroRNA‐31 targets FIH‐1 to positively regulate corneal epithelial glycogen metabolism
Peng, H., Hamanaka, R. B., Katsnelson, J., Hao, L., Yang, W., Chandel, N. S., & Lavker, R. M. (2012) · The FASEB Journal · doi:10.1096/fj.11-198515 · Cited by 63
Self-citationStricker, T. P., Brown, C. D., Bandlamudi, C., McNerney, M. E., Kittler, R., Montoya, V. R., Peterson, A. L., Grossman, R. L., & White, K. P. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006589 · Cited by 61
FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis
Chattaragada, M. S., Riganti, C., Sassoé‐Pognetto, M., Principe, M., Santamorena, M. M., Roux, C., Curcio, C., Evangelista, A., Allavena, P., Salvia, R., et al. (2017) · Oncogene · doi:10.1038/onc.2017.358 · Cited by 62
NF-κB and mitochondria cross paths in cancer: mitochondrial metabolism and beyond
Capece, D., Verzella, D., Francesco, B. D., Alesse, E., Franzoso, G., & Zazzeroni, F. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.021 · Cited by 66
Gomez-Jenkins, M., Shah, N., Kenny, T. C., Jenkins, E. C., & Germain, D. (2019) · Oncogene · doi:10.1038/s41388-019-0839-x · Cited by 61
Overview of Cancer Metabolism and Signaling Transduction
Chae, H., & Hong, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010012 · Cited by 66
Drivers of the Warburg Phenotype
Cairns, R. A. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000106 · Cited by 63
KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance
Ash, L. J., Busia-Bourdain, O., Okpattah, D., Kamel, A., Liberchuk, A., & Wolfe, A. L. (2024) · Current Oncology · doi:10.3390/curroncol31040150 · Cited by 68
“Notably, lung adenocarcinomas in smokers exhibit a higher frequency of G to T transversions compared to those in nonsmokers [35].”
BackgroundLi, Y., He, L., Zeng, N., Sahu, D., Cadenas, E., Shearn, C., Li, W., & Stiles, B. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.450353 · Cited by 58
Cross‐Talk between Oxidative Stress and m6A RNA Methylation in Cancer
Yang, B., & Chen, Q. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6545728 · Cited by 61
Cui, C., Yang, J., Fu, L., Wang, M., & Wang, X. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14632 · Cited by 59
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC
Lee, J.-S., Kang, J. H., Lee, S.-H., Hong, D., Son, J., Hong, K. M., Song, J., & Kim, S.-Y. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.404 · Cited by 56
Zhang, X., Li, C., Zhang, Y., Guan, X., Mei, L., Feng, H., Li, J., Tu, L., Feng, G., Deng, G., et al. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202207259 · Cited by 58
Metabolic dependencies and targets in ovarian cancer
Zhang, Y., Wang, Y., Zhao, G., Oršulić, S., & Matei, D. E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108413 · Cited by 65
Enhanced tumorigenicity by mitochondrial DNA mild mutations
Cruz‐Bermúdez, A., Vallejo, C. G., Vicente-Blanco, R. J., Gallardo, M. E., Fernández‐Moreno, M. Á., Quintanilla, M., & Garesse, R. (2015) · Oncotarget · doi:10.18632/oncotarget.3698 · Cited by 59
Tumorigenicity of hypoxic respiring cancer cells revealed by a hypoxia–cell cycle dual reporter
Le, A., Stine, Z. E., Nguyen, C. C., Afzal, J. M., Sun, P., Hamaker, M. C., Siegel, N. M., Gouw, A. M., Kang, B.-H., Yu, S.-H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402012111 · Cited by 61
Mitochondrial metabolism and energy sensing in tumor progression
Iommarini, L., Ghelli, A. M., Gasparre, G., & Porcelli, A. M. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.006 · Cited by 58
Essential roles of mitochondrial and heme function in lung cancer bioenergetics and tumorigenesis
Kalainayakan, S. P., FitzGerald, K. E., Konduri, P. C., Vidal, C., & Li, Z. (2018) · Cell & Bioscience · doi:10.1186/s13578-018-0257-8 · Cited by 59
Sun, W., Luan, S., Qi, C., Tong, Q., Yan, S., Li, H., & Zhang, Y. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0425-4 · Cited by 59
Chong, S. J. F., Iskandar, K. B., Lai, J. X. H., Qu, J., Raman, D., Valentin, R., Herbaux, C., Collins, M. C., Low, I. C. C., Loh, T. K. S., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1110 · Cited by 60
Amano, Y., Mandai, M., Yamaguchi, K. D., Matsumura, N., Kharma, B., Baba, T., Abiko, K., Hamanishi, J., Yoshioka, Y., & Konishi, I. (2015) · Oncotarget · doi:10.18632/oncotarget.4692 · Cited by 58
Peroxiredoxin 3 levels regulate a mitochondrial redox setpoint in malignant mesothelioma cells
Cunniff, B., Wozniak, A. N., Sweeney, P., DeCosta, K., & Heintz, N. H. (2014) · Redox Biology · doi:10.1016/j.redox.2014.11.003 · Cited by 56
Oxidative stress enhances Axl-mediated cell migration through an Akt1/Rac1-dependent mechanism
Huang, J.-S., Cho, C.-Y., Hong, C., Yan, M., Hsieh, M., Lay, J., Lai, G., Cheng, A., & Chuang, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.09.011 · Cited by 58
MicroRNAs in pancreatic cancer metabolism
Singh, P. K., Brand, R. E., & Mehla, K. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.63 · Cited by 59
Conceptual Framework for Cutting the Pancreatic Cancer Fuel Supply
Le, A., Rajeshkumar, N. V., Maitra, A., & Dang, C. V. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0041 · Cited by 57
The role of mitochondrial ATP synthase in cancer
Galber, C., Acosta, M. J., Minervini, G., & Giorgio, V. (2020) · Biological Chemistry · doi:10.1515/hsz-2020-0157 · Cited by 56
PAK and PI3K pathway activation confers resistance to KRASG12C inhibitor sotorasib
Chan, C.-H., Chiou, L.-W., Lee, T.-Y., Liu, Y.-R., Hsieh, T.-H., Yang, C.-Y., & Jeng, Y.-M. (2023) · British Journal of Cancer · doi:10.1038/s41416-022-02032-w · Cited by 56
Mitochondrial-targeted nanoparticles: Delivery and therapeutic agents in cancer
Ganji, C., Muppala, V., Khan, M., Nagaraju, G. P., & Farran, B. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103469 · Cited by 57
USP5-Beclin 1 axis overrides p53-dependent senescence and drives Kras-induced tumorigenicity
Li, J., Wang, Y., Luo, Y., Liu, Y., Yi, Y., Li, J., Pan, Y., Li, W., You, W., Hu, Q., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35557-y · Cited by 63
Keap1–Nrf2 signalling in pancreatic cancer
Hayes, A. J., Skouras, C., Haugk, B., & Charnley, R. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.06.017 · Cited by 56
Cancer: NF-κB regulates energy metabolism
Moretti, M., Bennett, J., Tornatore, L., Thotakura, A. K., & Franzoso, G. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.002 · Cited by 57
Fisher, K. W., Das, B., Kortum, R. L., Chaika, O. V., & Lewis, R. E. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05255-11 · Cited by 60
Niedźwiecka, K., Tisi, R., Penna, S., Lichocka, M., Płochocka, D., & Kucharczyk, R. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.10.003 · Cited by 58
New insights into acquired endocrine resistance of breast cancer
Fan, P., & Jordan, V. C. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.13 · Cited by 57
Connecting lysosomes and mitochondria – a novel role for lipid metabolism in cancer cell death
Bartel, K., Pein, H., Popper, B., Schmitt, S., Janaki‐Raman, S., Schulze, A., Lengauer, F., Koeberle, A., Werz, O., Zischka, H., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0399-2 · Cited by 56
Roles of Reactive Oxygen Species in Biological Behaviors of Prostate Cancer
Han, C., Wang, Z., Xu, Y., Chen, S., Han, Y., Li, L., Wang, M., & Xun-bo, J. (2020) · BioMed Research International · doi:10.1155/2020/1269624 · Cited by 57
Mitochondria–actin cytoskeleton crosstalk in cell migration
Yadav, T., Gau, D. M., & Roy, P. S. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30729 · Cited by 54
Glutathione in cancer progression and chemoresistance: an update
Valenti, G. E., Tasso, B., Traverso, N., Domenicotti, C., & Marengo, B. (2023) · Redox Experimental Medicine · doi:10.1530/rem-22-0023 · Cited by 57
Li, J., Csibi, A., Yang, S., Hoffman, G. R., Li, C., Zhang, E. Y., Yu, J. J., & Blenis, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417015112 · Cited by 55
RetractedEphA2/Ephrin-A1 Signaling Complexes Restrict Corneal Epithelial Cell Migration
Kaplan, N., Fatima, A., Peng, H., Bryar, P. J., Lavker, R. M., & Getsios, S. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8685 · Cited by 55
Mitochondrial dynamics: biology and therapy in lung cancer
Lennon, F. E., & Salgia, R. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.899350 · Cited by 55
Garama, D. J., Harris, T. J., White, C. L., Rossello, F. J., Abdul‐Hay, M., Gough, D. J., & Levy, D. E. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00541-15 · Cited by 58
Paradoxical roles of dual oxidases in cancer biology
Little, A. C., Sulovari, A., Danyal, K., Heppner, D. E., Seward, D. J., & van der Vliet, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.05.024 · Cited by 55
Shashni, B., & Nagasaki, Y. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.042 · Cited by 55
De novo lipogenesis represents a therapeutic target in mutant Kras non‐small cell lung cancer
Singh, A., Ruiz, C. F., Bhalla, K., Haley, J. D., Li, Q. K., Acquaah-Mensah, G. K., Montal, E. D., Sudini, K. R., Skoulidis, F., Wistuba, I. I., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800204 · Cited by 60
Possible Beneficial Effects of N-Acetylcysteine for Treatment of Triple-Negative Breast Cancer
Kwon, Y. (2021) · Antioxidants · doi:10.3390/antiox10020169 · Cited by 58
Understanding the Warburg Effect in CancerPreprint
Li, Z., Munim, M. B., Sharygin, D. A., Bevis, B. J., & Heiden, M. G. V. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041532 · Cited by 55
Yao, J., Zhou, E., Wang, Y., Xu, F., Zhang, D., & Zhong, D. (2014) · DNA and Cell Biology · doi:10.1089/dna.2013.2132 · Cited by 54
Lane, A. N., Tan, J. D., Wang, Y., Yan, J., Higashi, R. M., & Fan, T. W. ‐. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.01.010 · Cited by 55
Sestrins as a Therapeutic Bridge between ROS and Autophagy in Cancer
Sánchez‐Álvarez, M., Strippoli, R., Donadelli, M., Bazhin, A. V., & Cordani, M. (2019) · Cancers · doi:10.3390/cancers11101415 · Cited by 52
Ward, N. P., Kang, Y. P., Falzone, A., Boyle, T. A., & DeNicola, G. M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191689 · Cited by 55
Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy
Leone, R. D., & Powell, J. D. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0791 · Cited by 53
Mitochondria transcription and cancer
Tang, L., Rui, Y., Xiaoshuang, Z., Zhang, J., & Jihong, Z. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01926-3 · Cited by 59
The adaptor protein Miro1 modulates horizontal transfer of mitochondria in mouse melanoma models
Novák, J., Nahácka, Z., Oliveira, G. L., Brisudová, P., Dubisova, M., Dvorakova, S., Miklovicova, S., Dalecká, M., Puttrich, V., Grycová, L., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115154 · Cited by 52
Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer
Johnson, J. M., Lai, S. Y., Cotzia, P., Cognetti, D. M., Luginbuhl, A., Pribitkin, E. A., Zhan, T., Mollaee, M., Domingo‐Vidal, M., Chen, Y., et al. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.025 · Cited by 55
The role of mitochondria in the oncogenic signal transduction
Frezza, C. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.12.013 · Cited by 53
Verrax, J., Dejeans, N., Sid, B., Glorieux, C., & Calderón, P. B. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.102 · Cited by 54
Prx I Suppresses K-ras-Driven Lung Tumorigenesis by Opposing Redox-Sensitive ERK/Cyclin D1 Pathway
Park, Y., Kim, S., Lee, B.-K., Kim, H.-S., Song, I.-S., Shin, H.-J., Han, Y., Chang, K.-T., Kim, J., Lee, D., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4421 · Cited by 53
Time and Circumstances: Cancer Cell Metabolism at Various Stages of Disease Progression
Weber, G. F. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00257 · Cited by 56
Wrzesinski, K., & Fey, S. J. (2018) · Bioengineering · doi:10.3390/bioengineering5010022 · Cited by 55
Pro- and antitumor effects of mitochondrial reactive oxygen species
Payen, V. L., Zampieri, L. X., Porporato, P. E., & Sonveaux, P. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09789-2 · Cited by 56
Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death
Läsche, M., Emons, G., & Gründker, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00409 · Cited by 55
Amoêdo, N. D., Sarlak, S., Obre, É., Estèves, P., Bégueret, H., Kieffer, Y., Rousseau, B., Alexis, D., Izotte, J., Bellancé, N., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci133081 · Cited by 57
N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages
Menga, A., Favia, M., Spera, I., Vegliante, M. C., Gissi, R., Grassi, A., Laera, L., Campanella, A., Gerbino, A., Carrà, G., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051981 · Cited by 57
Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer
Ni, R., Li, Z., Li, L., Peng, D., Ming, Y., Li, L., & Liu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1143798 · Cited by 57
Distinct Metabolomic Profiles of Papillary Thyroid Carcinoma and Benign Thyroid Adenoma
Xu, Y., Zheng, X., Qiu, Y., Jia, W. P., Wang, J., & Yin, S. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00351 · Cited by 54
Bowman, C. E., Zhao, L., Härtung, T., & Wolfgang, M. J. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00166-16 · Cited by 52
RAS signalling in energy metabolism and rare human diseases
Dard, L., Bellancé, N., Lacombe, D., & Rossignol, R. (2018) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2018.05.003 · Cited by 56
Glutamine metabolism in cancer therapy
Nguyen, T.-L., & Durán, R. V. (2018) · Cancer Drug Resistance · doi:10.20517/cdr.2018.08 · Cited by 56
Cysteine-based regulation of redox-sensitive Ras small GTPases
Messina, S., Simone, G. D., & Ascenzi, P. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101282 · Cited by 52
Wan, Q.-L., Fu, X., Meng, X., Luo, Z., Dai, W., Yang, J., Wang, C., Wang, H., & Zhou, Q. (2019) · Food & Function · doi:10.1039/c9fo02000d · Cited by 54
Exploring the role of glucose‑6‑phosphate dehydrogenase in cancer (Review)
Li, R., Wang, W., Yang, Y., & Gu, C. (2020) · Oncology Reports · doi:10.3892/or.2020.7803 · Cited by 52
The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer
Hon, K. W., Abidin, S. A. Z., Othman, I., & Naidu, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.768861 · Cited by 53
Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions
Laka, K., Makgoo, L., & Mbita, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.841639 · Cited by 51
Mitochondrial redox adaptations enable alternative aspartate synthesis in SDH-deficient cells
Hart, M. L., Quon, E., Vigil, A.-L. B. G., Engström, I., Newsom, O. J., Davidsen, K., Hoellerbauer, P., Carlisle, S. M., & Sullivan, L. B. (2023) · eLife · doi:10.7554/elife.78654 · Cited by 50
Current perspectives of mitochondria-targeted antioxidants in cancer prevention and treatment
Zinovkin, R. A., Lyamzaev, K. G., & Chernyak, B. V. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1048177 · Cited by 56
Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesis
Lin, H., Chung, Y., Cheng, C.-T., Ouyang, C., Fu, Y., Kuo, C., Chi, K. K., Sadeghi, M., Chu, P. G., Kung, H.-J., et al. (2018) · Autophagy · doi:10.1080/15548627.2018.1450708 · Cited by 53
Discovery and development of small molecule modulators targeting glutamine metabolism
Li, L., Meng, Y., Li, Z., Dai, W., Xu, X. J., Xiao-ling, B., & Bian, J. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.066 · Cited by 50
Park, S. H., Safi, R., Liu, X., Baldi, R. M., Liu, W., Liu, J., Locasale, J. W., Chang, C., & McDonnell, D. P. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.066 · Cited by 48
Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression
Vasconcelos-dos-Santos, A., de Queiroz, R. M., Rodrigues, B. D. C., Todeschini, A. R., & Dias, W. B. (2018) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-017-9740-x · Cited by 53
Lorente, J., Velandia, C., Leal, J. A., Garcia‐Mayea, Y., Lyakhovich, A., Kondoh, H., & LLeonart, M. E. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12337 · Cited by 51
Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies
de Wit, S., Glen, C., de Boer, R. A., & Lang, N. N. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac132 · Cited by 54
Reactive oxygen species formation and its effect on CD4+ T cell-mediated inflammation
Shu, P., Liang, H., Zhang, J., Lin, Y., Chen, W., & Zhang, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199233 · Cited by 58
Nuclear Lamins and Oxidative Stress in Cell Proliferation and Longevity
Shimi, T., & Goldman, R. D. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-8032-8_19 · Cited by 54
Han, B., Izumi, H., Yasuniwa, Y., Akiyama, M., Yamaguchi, T., Fujimoto, N., Matsumoto, T., Wu, B., Tanimoto, A., Sasaguri, Y., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.114 · Cited by 50
Han, J., & Theiss, A. L. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000180 · Cited by 52
Role of ginsenosides in reactive oxygen species-mediated anticancer therapy
Sodrul, I. M. D., Wang, C., Chen, X., Du, J., & Sun, H. (2017) · Oncotarget · doi:10.18632/oncotarget.23407 · Cited by 50
Bejoy, J., Yuan, X., Song, L., Hua, T., Jeske, R., Sart, S., Sang, Q. A., & Li, Y. (2019) · Stem Cells International · doi:10.1155/2019/2382534 · Cited by 52
Metadata
- Authors
- Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S.
- Affiliations
- Northwestern University (US)
- Division of Pulmonary and Critical Care, Department of Medicine,
- Medical College of Wisconsin (US)
- Department of Biophysics and Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-04-26
- Volume
- 107
- Issue
- 19
- Pages
- 8788-8793
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2889315
- OpenAlex
- W1982330633
- Cited by
- 1,742
- References
- 29
- Citations by year
- 2026: 63 · 2025: 100 · 2024: 124 · 2023: 122 · 2022: 149 · 2021: 154 · 2020: 137 · 2019: 138 · 2018: 111 · 2017: 108 · 2016: 100 · 2015: 113 · 2014: 89 · 2013: 77 · 2012: 77
- FWCI
- 23.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000201)
- LUNGevity Foundation
- Respiratory Health Association of Metropolitan Chicago
- Respiratory Health Association
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01HL071643)
- National Cancer Institute (R01CA125112, R01CA152810, R01CA123067, CA125112, P30CA060553, T32CA070085, T32CA009560)
- National Institute of Environmental Health Sciences (ES 013995, ES015024, R01ES013995, R01ES015024)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- KRAS, mitochondrial metabolism, reactive oxygen species, pentose phosphate pathway, aerobic glycolysis, Warburg effect, anchorage-independent growth, glutaminase, alpha-ketoglutarate, TCA cycle, ERK signaling, mitochondrial complex III, TFAM, lung cancer, carcinogenesis, hypoxia
- MeSH terms
- Aerobiosis, Animals, Cell Adhesion, Cell Transformation, Neoplastic, Glutamine, Glycolysis, Humans, Lung Neoplasms, Mitochondria, Oxidative Phosphorylation, Pentose Phosphate Pathway, Electron Transport Complex III, Proto-Oncogene Proteins p21(ras), Reactive Oxygen Species, HCT116 Cells, Extracellular Signal-Regulated MAP Kinases, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
